FI792969A - 5-(4-pyridyl)-6-(4-fluorfenyl)-2,3-dihydroimidazo(2,1-b)tiazol - Google Patents

5-(4-pyridyl)-6-(4-fluorfenyl)-2,3-dihydroimidazo(2,1-b)tiazol

Info

Publication number
FI792969A
FI792969A FI792969A FI792969A FI792969A FI 792969 A FI792969 A FI 792969A FI 792969 A FI792969 A FI 792969A FI 792969 A FI792969 A FI 792969A FI 792969 A FI792969 A FI 792969A
Authority
FI
Finland
Prior art keywords
pyridyl
dihydroimidazo
fluorfenyl
tiazol
fluorophenyl
Prior art date
Application number
FI792969A
Other languages
English (en)
Other versions
FI65435C (fi
FI65435B (fi
Inventor
Paul Elliot Bender
Ivan Lantos
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of FI792969A publication Critical patent/FI792969A/fi
Application granted granted Critical
Publication of FI65435B publication Critical patent/FI65435B/fi
Publication of FI65435C publication Critical patent/FI65435C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Cosmetics (AREA)
  • Glass Compositions (AREA)
FI792969A 1978-09-27 1979-09-24 Foerfarande foer framstaellning av immunitet raglerande och arrit motstaoende 5-(4-pyridyl)-6-(4-fluorfenyl)-2,3-dihydr oiidazo-(2,1-b)tiazol FI65435C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94626078 1978-09-27
US05/946,260 US4175127A (en) 1978-09-27 1978-09-27 Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles

Publications (3)

Publication Number Publication Date
FI792969A true FI792969A (fi) 1980-03-28
FI65435B FI65435B (fi) 1984-01-31
FI65435C FI65435C (fi) 1984-05-10

Family

ID=25484215

Family Applications (1)

Application Number Title Priority Date Filing Date
FI792969A FI65435C (fi) 1978-09-27 1979-09-24 Foerfarande foer framstaellning av immunitet raglerande och arrit motstaoende 5-(4-pyridyl)-6-(4-fluorfenyl)-2,3-dihydr oiidazo-(2,1-b)tiazol

Country Status (29)

Country Link
US (1) US4175127A (fi)
EP (1) EP0011111B1 (fi)
JP (1) JPS5545700A (fi)
AT (1) ATE1587T1 (fi)
AU (1) AU523815B2 (fi)
CA (1) CA1128947A (fi)
CS (1) CS208153B2 (fi)
DD (1) DD146293A5 (fi)
DE (1) DE2963737D1 (fi)
DK (1) DK146339C (fi)
EG (1) EG14013A (fi)
ES (1) ES484450A1 (fi)
FI (1) FI65435C (fi)
GR (1) GR69989B (fi)
HU (1) HU182595B (fi)
IE (1) IE49077B1 (fi)
IL (1) IL58309A (fi)
IN (1) IN152859B (fi)
IT (1) IT1123753B (fi)
MX (1) MX6186E (fi)
NO (1) NO150839C (fi)
NZ (1) NZ191632A (fi)
PH (1) PH14326A (fi)
PL (1) PL117755B1 (fi)
PT (1) PT70209A (fi)
RO (1) RO77750A (fi)
SU (1) SU940649A3 (fi)
YU (1) YU40761B (fi)
ZA (1) ZA794045B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1302A (en) * 1978-04-11 1985-12-06 Ciba Geigy Ag Mercapto-imidazole derivatives,their preparation,their pharmaceutical compositions and applications
PL221188A1 (fi) * 1979-01-05 1980-12-01 Ciba Geigy Ag
US5008390A (en) * 1985-05-23 1991-04-16 Smithkline Beckman Corporation Compounds for preparing 6-phenyl-2,3-dihydroimidazo[2,1-b]-thiazoles and corresponding thiazines
IL78834A (en) * 1985-05-23 1992-07-15 Smithkline Beckman Corp 2,3-dihydro-5-(1,4-dihydropyridin-4-yl)-6-phenylimidazo(2,1-b)thiazoles and 6,7-dihydro-3-(1,4-dihydropyridin-4-yl)-2-phenyl-5h-imidazo(2,1-b)(1,3)thiazines and their use as intermediates in a process for preparing the corresponding pyridyl-substituted imidazo(2,1-b)thiazoles and 5h-imidazo(2,1-b)(1,3)thiazines
US4803279A (en) * 1985-05-23 1989-02-07 Smithkline Beckman Corporation 1.4-dihydro-4-pyridyl-substituted imidazo (2,1-b) thiazoles and the corresponding thiazines.
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4719218A (en) * 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
ZW24186A1 (en) * 1985-12-12 1987-07-08 Smithkline Beckman Corp Inhibition of the 5-lipoxygenase pathway
US5134150A (en) * 1985-12-12 1992-07-28 Smithkline Beecham Corporation Inhibition of the 5-lipoxygenase pathway
US4751310A (en) * 1985-12-12 1988-06-14 Smithkline Beckman Corporation Inhibition of the 5-lipoxygenase pathway
US5145858A (en) * 1985-12-12 1992-09-08 Smithkline Beecham Corp. Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4794114A (en) * 1986-08-19 1988-12-27 Smithkline Beckman Corporation Inhibition of interleukin-1 production by monocytes and/or macrophages
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
MY103766A (en) * 1987-09-02 1993-09-30 Smithkline Beckman Corp Pyrrolo[1,2-a]imidazole and imidazo[1,2-a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
AU6355190A (en) * 1989-06-13 1991-01-17 Smithkline Beecham Corporation Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
ES2053401B1 (es) * 1992-01-13 1995-03-01 Smithkline Beecham Corp Compuestos de imidazol y procedimientos para su prepacion.
MX9300141A (es) * 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
US5656644A (en) * 1994-07-20 1997-08-12 Smithkline Beecham Corporation Pyridyl imidazoles
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US6426360B1 (en) * 1994-07-28 2002-07-30 G D Searle & Co. 4,5-substituted imidazolyl compounds for the treatment of inflammation
US5552422A (en) * 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
US20030050330A1 (en) * 1997-01-10 2003-03-13 G.D. Searle & Co. 4,5-subtstituted imdazolyl compounds for the treatment of inflammation
WO1998056788A1 (en) 1997-06-12 1998-12-17 Rhone-Poulenc Rorer Limited Imidazolyl-cyclic acetals
WO1999003837A1 (en) * 1997-06-30 1999-01-28 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
BR112014000774B1 (pt) * 2011-07-13 2022-03-29 Tiumbio Co., Ltd Compostos imidazóis substituídos por 2-piridila como inibidores de alk5 e/ou alk4, composição farmacêutica compreendendo-os e uso terapêutico dos mesmos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1488271A (fr) * 1966-03-21 1967-07-13 Chimetron Sarl Nouveaux anthelminthiques imidazothiazoliques
FR1488322A (fr) * 1966-04-28 1967-07-13 Chimetron Sarl Dérivés pyridiniques de l'imidazo [2, 1-b] thiazole
GB1541321A (en) * 1976-03-10 1979-02-28 Metabio 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation
US4064260A (en) * 1976-07-29 1977-12-20 E. I. Du Pont De Nemours And Company Anti-inflammatory diarylimidazothiazoles and their corresponding S-oxides
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen

Also Published As

Publication number Publication date
AU5111779A (en) 1980-04-03
SU940649A3 (ru) 1982-06-30
PL117755B1 (en) 1981-08-31
DK400879A (da) 1980-03-28
IL58309A0 (en) 1979-12-30
EG14013A (en) 1983-03-31
YU40761B (en) 1986-06-30
DD146293A5 (de) 1981-02-04
RO77750A (ro) 1981-11-24
IE49077B1 (en) 1985-07-24
ATE1587T1 (de) 1982-10-15
HU182595B (en) 1984-02-28
CA1128947A (en) 1982-08-03
NO150839B (no) 1984-09-17
NO150839C (no) 1985-01-09
US4175127A (en) 1979-11-20
JPS5545700A (en) 1980-03-31
IE791833L (en) 1980-03-27
ES484450A1 (es) 1980-05-16
AU523815B2 (en) 1982-08-19
EP0011111B1 (en) 1982-09-22
NO793076L (no) 1980-03-28
YU231679A (en) 1983-01-21
IT1123753B (it) 1986-04-30
FI65435C (fi) 1984-05-10
DK146339C (da) 1984-02-20
EP0011111A1 (en) 1980-05-28
PH14326A (en) 1981-05-27
IT7926051A0 (it) 1979-09-27
FI65435B (fi) 1984-01-31
IL58309A (en) 1984-03-30
MX6186E (es) 1984-12-11
IN152859B (fi) 1984-04-21
JPS6157833B2 (fi) 1986-12-09
DE2963737D1 (en) 1982-11-04
GR69989B (fi) 1982-07-23
DK146339B (da) 1983-09-12
PL218526A1 (fi) 1980-06-16
ZA794045B (en) 1980-09-24
PT70209A (en) 1979-10-01
NZ191632A (en) 1981-03-16
CS208153B2 (en) 1981-08-31

Similar Documents

Publication Publication Date Title
FI792969A (fi) 5-(4-pyridyl)-6-(4-fluorfenyl)-2,3-dihydroimidazo(2,1-b)tiazol
IE790676L (en) N-heterocyclyl-4-piperidinamines
IT7946846A0 (it) Procedimento per la produzione dimateriali composti
DK196287A (da) Slagseje polyamid-formmasser
GB2013716B (en) Production of volatile organic compounds by continuous fermentation
RO76811A (ro) Procedeu pentru prepararea unor oximinotriozolitani
ES452290A1 (es) Procedimiento para la preparacion de 1,4-bis (azolil-(2)- naftalina.
ES486652A1 (es) Procedimiento de obtencion de 2-cloro-5-trifluormetilpiridi-na y 2-cloro-5-perclorofluormetilpiridinas
RO76593A (ro) Procedeu pentru prepararea unor n-azolilalchil-halogen-acetanilide
AU4775679A (en) Novel compounds of the muramyl-peptide type
NO151821C (no) Fremgangsmaate til fremstilling av 1,2-diklor-etan ved oksyklorering av etylen
ES459494A1 (es) Procedimiento de preparacion de hidrox-alfa-aminobencilpeni-cilina.
IT7829711A0 (it) Procedimento per la preparazione di composti organici dello stagno.
SE7902404L (sv) 2,3-dihydro-4h-1-bensopyran-4-on-o-karbamoyloximer
RO76374A (ro) Procedeu de preparare a unor spiro-derivati de 3-(3,5-dihalofenil)-oxazolidin-2,4-diona
SU652142A1 (ru) Шихта дл изготовлени строительных изделий
AU5360579A (en) Spiro-derivatives of 3-(3,5-dihalogeno-phenyl)-oxazolidine -2,4-diones
DE2960020D1 (en) Process for the preparation of tris(8-hydroxy-3,6-dioxa-octyl)-amine, and the compound obtained by this process
SE8103939L (sv) Indolo(2';3,4)pyrido(2,1-b)kinazolin-5-oner jemte sett for deras framstellning
JPS57150692A (en) 4-hetero ring-substituted-2,6-di-tert-butyl-phenol derivative
SU669683A1 (ru) Галогенпроизводные 2-бензилиденгидразиноциклогексено [d]тиазола, обладающие акарицидной активностью
IT7823095A0 (it) Procedimento per la preparazione di composti organici dello stagno.
NO781545L (no) Fremgangsmaate for fremstilling av organiske forbindelser
NO160210C (no) N-trimetylsilyloksykarbonyl-6-aminopenicillinmellomprodukt for fremstilling av et penicillin.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SMITHKLINE BECKMAN CORPORATION